Nuvalent Inc vs Veritone Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: Nuvalent Inc is far larger — about 100.5× Veritone Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | VERI | |
|---|---|---|
Market Cap | $9.81B | $97.60M |
Sector | Technology | Technology |
52-Week High | $123.96 | $8.39 |
52-Week Low | $72.16 | $1.02 |
Enterprise Value | $8.52B | $129.63M |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →